Vineet Laboratories
VINEETLABNSE

Vineet Laboratories

₹34.550.16 (0.47%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
34.00
Today’s high
34.80
52 week low
24.01
52 week high
43.50
Open price
34.80
Previous close
34.39
Live volume
--
Lower circuit
32.68
Upper circuit
36.10

Fundamentals

Market Cap
₹68Cr
ROE
-117.41%
P/E Ratio(TTM)
--
EPS(TTM)
-5.28
P/B Ratio
1.53
Dividend Yield
0.00%
Industry P/E
44.37
Book Value
23.00
Debt to Equity
3.01
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹15.70
-9.93%
Profit (Cr)
₹0.85
+112.50%
-20-1001020
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-13%
3Y CAGR-26%
Profit growthValue
1Y (TTM)+115%

About

Vineet Laboratories Limited manufactures active pharmaceutical ingredients (APIs) and intermediates, specializing in anti-diabetic and anti-hypertensive drugs.;
CEO/MD
Mr Gaddam Venkata Ramana
Founded in
2016
NSE symbol
VINEETLAB

Shareholding Pattern

Jun '25
Sep '25
Dec '25
Feb '26
Mar '26
Retail And Others
93.66%
Promoters
5.98%
Foreign Institutions
0.36%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹193.74
-1.39 (0.71%)
L
    H
    3,059.6231.370.46
    Vimta LabsVIMTALABS
    ₹522.15
    +8.90 (1.73%)
    L
      H
      2,297.5729.655.03
      ₹830.30
      +24.45 (3.03%)
      L
        H
        1,661.9425.012.86
        ₹650.00
        -2.25 (0.34%)
        L
          H
          837.3347.165.14
          2026
          30
          May
          Annual Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2025

          23
          Dec
          Rights Entitlement
          Ex date
          13:12
          Ratio

          13 rights eligible for every 12 existing shares held
          Ratio13:12
          Offer price₹30.00
          Ex date23 Dec ‘25
          Record date23 Dec ‘25
          Announcement date17 Dec ‘25

          17
          Dec
          Rights Entitlement
          Announced
          13:12
          Ratio

          13 rights eligible for every 12 existing shares held
          Ratio13:12
          Offer price₹30.00
          Ex date23 Dec ‘25
          Record date23 Dec ‘25
          Announcement date17 Dec ‘25
          8
          Nov
          Quarterly Result
          Release date
          23
          Oct
          Quarterly Result
          Release date
          22
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks